A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

Hundreds of Britons are being rushed to hospital with serious reactions to weight-loss drugs, with cases surging by 46 per ...

New data obtained has found cases soared over the four weeks to the end of November, with an extra 118 hospitalisations ...

Professor Naveed Sattar, the Government's leader on obesity healthcare goals has revealed the real reason why so many Brits ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...

Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...